• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化学预防剂可抑制从Apc 1638N [+/-]小鼠建立的结肠上皮细胞系中异倍体表型的异常增殖。

Chemopreventive agents inhibit aberrant proliferation of the aneuploid phenotype in a colon epithelial cell line established from Apc 1638N [+/-] mouse.

作者信息

Katdare M, Kopelovich L, Telang N

机构信息

Chemoprevention Research Laboratory, Strang Cancer Prevention Center, New York, New York 10021, USA.

出版信息

Ann N Y Acad Sci. 2001 Dec;952:169-74. doi: 10.1111/j.1749-6632.2001.tb02738.x.

DOI:10.1111/j.1749-6632.2001.tb02738.x
PMID:11795437
Abstract

Loss of function of the adenomatous polyposis coli (APC) tumor suppressor gene predisposes for familial adenomatous polyposis (FAP) syndrome. The Apc gene knockout mice exhibit accelerated intestinal carcinogensis modifiable by diverse pharmacological agents. Present experiments utilized the Apc[+/-] 1638N COL colon epithelial cell line (origin: histologically normal colon) as the model. Retinoid receptor modulator 9-cis-retinoic acid (9-cis-RA), ornithine decarboxylase inhibitor difluoromethyl ornithine (DFMO), and nonselective cyclooxygenase inhibitor sulindac (SUL) represented the chemopreventive test compounds. Population doubling, cell cycle progression, and anchorage-independent growth provided mechanistic end points for chemopreventive efficacy. Treatment of 1638N COL cells with 9-cis-RA, DFMO and SUL produced a dose-dependent cytostatic growth arrest by decreasing the number of population doublings and altering aneuploid G0/G1:S+G2/M ratio. The clonally expanded 1638N-Cl1 cells selected for anchorage-independent growth exhibited decreased anchorage-independent colony formation in response to treatment with the three test compounds. Susceptibility of preneoplastic 1638N COL cells to mechanistically distinct chemopreventive agents validates a unique epithelial cell culture model for FAP syndrome, and facilitates investigations on Apc regulated colon carcinogenesis and cancer prevention.

摘要

腺瘤性结肠息肉病(APC)肿瘤抑制基因功能丧失易引发家族性腺瘤性息肉病(FAP)综合征。Apc基因敲除小鼠表现出加速的肠道癌变,可被多种药物改变。目前的实验使用Apc[+/-] 1638N COL结肠上皮细胞系(来源:组织学正常的结肠)作为模型。视黄酸受体调节剂9-顺式视黄酸(9-cis-RA)、鸟氨酸脱羧酶抑制剂二氟甲基鸟氨酸(DFMO)和非选择性环氧化酶抑制剂舒林酸(SUL)代表化学预防测试化合物。群体倍增、细胞周期进程和不依赖贴壁生长为化学预防效果提供了机制性终点。用9-cis-RA、DFMO和SUL处理1638N COL细胞,通过减少群体倍增数和改变非整倍体G0/G1:S+G2/M比率,产生了剂量依赖性的细胞生长抑制。为不依赖贴壁生长而选择的克隆扩增的1638N-Cl1细胞,在接受三种测试化合物处理后,不依赖贴壁的集落形成减少。癌前1638N COL细胞对机制不同的化学预防剂的敏感性验证了一种针对FAP综合征的独特上皮细胞培养模型,并有助于对Apc调节的结肠癌发生和癌症预防进行研究。

相似文献

1
Chemopreventive agents inhibit aberrant proliferation of the aneuploid phenotype in a colon epithelial cell line established from Apc 1638N [+/-] mouse.化学预防剂可抑制从Apc 1638N [+/-]小鼠建立的结肠上皮细胞系中异倍体表型的异常增殖。
Ann N Y Acad Sci. 2001 Dec;952:169-74. doi: 10.1111/j.1749-6632.2001.tb02738.x.
2
Novel cell culture model for prevention of carcinogenic risk in familial adenomatous polyposis syndrome.用于预防家族性腺瘤性息肉病综合征致癌风险的新型细胞培养模型。
Oncol Rep. 2009 Apr;21(4):1017-21. doi: 10.3892/or_00000318.
3
Efficacy of chemopreventive agents for growth inhibition of Apc [+/-] 1638NCOL colonic epithelial cells.
Int J Mol Med. 2002 Oct;10(4):427-32.
4
Combinatorial prevention of carcinogenic risk in a model for familial colon cancer.家族性结肠癌模型中致癌风险的联合预防
Oncol Rep. 2007 Apr;17(4):909-14.
5
Cell culture model for colon cancer prevention and therapy: an alternative approach to animal experimentation.用于结肠癌预防和治疗的细胞培养模型:动物实验的替代方法。
ALTEX. 2007;24(1):16-21. doi: 10.14573/altex.2007.1.16.
6
Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.吡罗昔康与二氟甲基鸟氨酸联合治疗Apc突变型Min小鼠腺瘤的化学预防效果及对Apc突变胚胎的选择性毒性。
Cancer Res. 2000 Apr 1;60(7):1864-70.
7
Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).用于乳腺癌和结肠癌的基因工程小鼠的临床前体外模型(综述)。
Oncol Rep. 2011 May;25(5):1195-201. doi: 10.3892/or.2011.1215. Epub 2011 Mar 10.
8
Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer.在遗传性结肠癌的细胞模型中,抗炎药耐药性会选择假定的癌症干细胞。
Oncol Lett. 2018 Jan;15(1):642-648. doi: 10.3892/ol.2017.7147. Epub 2017 Oct 6.
9
Stem cell models for genetically predisposed colon cancer.遗传性结肠癌的干细胞模型。
Oncol Lett. 2020 Nov;20(5):138. doi: 10.3892/ol.2020.11998. Epub 2020 Aug 20.
10
Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.特异性环氧化酶-2抑制剂罗非昔布对Apcdelta716小鼠肠道息肉病的化学预防作用
Cancer Res. 2001 Feb 15;61(4):1733-40.